Catalyst Wire Dossier Catalyst Wire Dossier

Pegamotecan

pegamotecan · Enzon Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegamotecan, covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction [Phase 2]

See pricing